Efferent Labs raised a round of funding on October 30, 2014. Investors include 43North.

Efferent Labs, formerly Raland Therapeutics, is a preclinical stage medical technology company focused on implantable biosensors. The company's CytoComm Biosensor Platform is designed to serve as a re…